- Home
- DRUG vs ANGO Comparison
DRUG vs ANGO Comparison
Compare DRUG & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- ANGO
- Stock Information
- Founded
- DRUG 2019
- ANGO 1988
- Country
- DRUG United States
- ANGO United States
- Employees
- DRUG N/A
- ANGO N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- ANGO Medical/Dental Instruments
- Sector
- DRUG Health Care
- ANGO Health Care
- Exchange
- DRUG Nasdaq
- ANGO Nasdaq
- Market Cap
- DRUG 345.6M
- ANGO 400.8M
- IPO Year
- DRUG N/A
- ANGO 2004
- Fundamental
- Price
- DRUG $45.43
- ANGO $10.48
- Analyst Decision
- DRUG Strong Buy
- ANGO Strong Buy
- Analyst Count
- DRUG 9
- ANGO 3
- Target Price
- DRUG $81.67
- ANGO $19.00
- AVG Volume (30 Days)
- DRUG 70.6K
- ANGO 370.2K
- Earning Date
- DRUG 08-11-2025
- ANGO 10-02-2025
- Dividend Yield
- DRUG N/A
- ANGO N/A
- EPS Growth
- DRUG N/A
- ANGO N/A
- EPS
- DRUG N/A
- ANGO N/A
- Revenue
- DRUG N/A
- ANGO $292,498,000.00
- Revenue This Year
- DRUG N/A
- ANGO $7.13
- Revenue Next Year
- DRUG N/A
- ANGO $6.28
- P/E Ratio
- DRUG N/A
- ANGO N/A
- Revenue Growth
- DRUG N/A
- ANGO N/A
- 52 Week Low
- DRUG $0.94
- ANGO $5.83
- 52 Week High
- DRUG $79.02
- ANGO $13.50
- Technical
- Relative Strength Index (RSI)
- DRUG 57.15
- ANGO 52.63
- Support Level
- DRUG $39.70
- ANGO N/A
- Resistance Level
- DRUG $49.49
- ANGO $11.04
- Average True Range (ATR)
- DRUG 3.14
- ANGO 0.30
- MACD
- DRUG 0.13
- ANGO -0.39
- Stochastic Oscillator
- DRUG 64.66
- ANGO 94.24
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.